Market Overview:
The global interventional cardiovascular device market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, technological advancements in interventional devices, and rising demand for minimally invasive procedures. Based on type, the global interventional cardiovascular device market is segmented into imaging systems, catheters, PTCA balloons, stents, PTCA guidewires and others. Imaging systems are further sub-segmented into X-ray systems and ultrasound systems. Catheters are further sub-segmented into guiding catheters and inflation/deflation catheters. The PTCA balloon segment is expected to grow at the highest CAGR during the forecast period owing to its growing use in percutaneous coronary interventions (PCI). Based on application, the global interventional cardiovascular device market is segmented into hospitals and clinics. Hospitals are further sub-segmented into cardiology departments and general surgery departments while clinics are sub-segmented into cardiology clinics and vascular surgery clinics.
Product Definition:
An interventional cardiovascular device is a tool used by doctors to help them treat heart conditions. These devices can include stents, balloons, and other tools used during procedures such as angioplasty or heart bypass surgery.
Imaging System:
Imaging system is a medical device that helps in capturing images of targeted body parts and transmitting them to the healthcare professional for effective treatment. Imaging systems are widely used in interventional cardiology to guide catheters, introduce stents, injectable devices & other accessories during minimally invasive surgeries.
The global imaging system market was valued at USD 5.6 billion in 2015.
Catheter:
A catheter is a hollow tube used to introduce medical devices and injectable drugs into the body. The most commonly used catheters are angiography, cardiac electrophysiology testing, cardiac ablation (balloon angioplasty), percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery, peripheral vascular interventions like peripheral interventional radiology or endovascular procedures.
Application Insights:
The hospital application segment dominated the market in 2017 and is expected to witness a CAGR of XX% over the forecast period owing to increasing geriatric population, which increases the risk of cardiovascular diseases. Moreover, rising number of hospitals and clinics has resulted in increased adoption of interventional cardiac devices for treating patients with heart related problems.
The clinic application segment is expected to witness growth at a fastest rate during the forecast period owing to growing awareness about availability of advanced technologies for treating patients suffering from cardiovascular diseases at an affordable cost as compared with conventional treatment methods such as open heart surgery or valve replacement surgeries. In addition, favorable government initiatives such as National Cholesterol Education Program (NCEP) are anticipated to boost product demand over the coming years.
Regional Analysis:
North America dominated the global market in 2017 owing to the increasing prevalence of cardiovascular diseases, rising adoption of advanced technologies, and presence of key players in this region. Moreover, growing number of FDA approvals for various devices is also expected to drive growth during the forecast period. For instance, In April 2016, St. Jude Medical Inc received clearance from FDA for its real-time MRI compatible CardioSTAT heart monitor which was designed specifically for children over 1 year old at risk for sudden cardiac death syndrome (SCD).
Asia Pacific is anticipated to be one of the fastest-growing regions due to factors such as improving healthcare infrastructure and growing target population base especially in China & India. Furthermore, a large number of people are still not aware about their medical condition or treatment options which leads them to avoid seeking treatment until it becomes serious thereby creating huge potential opportunity space over next eight years.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive procedures
- Technological advancements in interventional cardiovascular devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Interventional Cardiovascular Device Market Research Report
By Type
Imaging System, Catheter, PTCA Balloon, Stent, PTCA Guidewire, Others
By Application
Hospital, Clinic
By Companies
GE Healthcare, Boston Scientific, Philips, Volcano Therapeutics, Argon Medical, Spectranetics, Angio Dynamics, AccessClosure, Merit Medical Systems, B. Braun, C. R. Bard, Marine Polymer Technologies, Cordis
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Interventional Cardiovascular Device Market Report Segments:
The global Interventional Cardiovascular Device market is segmented on the basis of:
Types
Imaging System, Catheter, PTCA Balloon, Stent, PTCA Guidewire, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Boston Scientific
- Philips
- Volcano Therapeutics
- Argon Medical
- Spectranetics
- Angio Dynamics
- AccessClosure
- Merit Medical Systems
- B. Braun
- C. R. Bard
- Marine Polymer Technologies
- Cordis
Highlights of The Interventional Cardiovascular Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Imaging System
- Catheter
- PTCA Balloon
- Stent
- PTCA Guidewire
- Others
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Interventional Cardiovascular Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Interventional cardiovascular devices are medical devices that are inserted into the body to treat heart disease or other conditions. These devices can include stents, pacemakers, and defibrillators.
Some of the major players in the interventional cardiovascular device market are GE Healthcare, Boston Scientific, Philips, Volcano Therapeutics, Argon Medical, Spectranetics, Angio Dynamics, AccessClosure, Merit Medical Systems, B. Braun, C. R. Bard, Marine Polymer Technologies, Cordis.
The interventional cardiovascular device market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Interventional Cardiovascular Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Interventional Cardiovascular Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Interventional Cardiovascular Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Interventional Cardiovascular Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Interventional Cardiovascular Device Market Size & Forecast, 2020-2028
4.5.1 Interventional Cardiovascular Device Market Size and Y-o-Y Growth
4.5.2 Interventional Cardiovascular Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Imaging System
5.2.2 Catheter
5.2.3 PTCA Balloon
5.2.4 Stent
5.2.5 PTCA Guidewire
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Interventional Cardiovascular Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Interventional Cardiovascular Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Imaging System
9.6.2 Catheter
9.6.3 PTCA Balloon
9.6.4 Stent
9.6.5 PTCA Guidewire
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Imaging System
10.6.2 Catheter
10.6.3 PTCA Balloon
10.6.4 Stent
10.6.5 PTCA Guidewire
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Imaging System
11.6.2 Catheter
11.6.3 PTCA Balloon
11.6.4 Stent
11.6.5 PTCA Guidewire
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Imaging System
12.6.2 Catheter
12.6.3 PTCA Balloon
12.6.4 Stent
12.6.5 PTCA Guidewire
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Imaging System
13.6.2 Catheter
13.6.3 PTCA Balloon
13.6.4 Stent
13.6.5 PTCA Guidewire
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Interventional Cardiovascular Device Market: Competitive Dashboard
14.2 Global Interventional Cardiovascular Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GE Healthcare
14.3.2 Boston Scientific
14.3.3 Philips
14.3.4 Volcano Therapeutics
14.3.5 Argon Medical
14.3.6 Spectranetics
14.3.7 Angio Dynamics
14.3.8 AccessClosure
14.3.9 Merit Medical Systems
14.3.10 B. Braun
14.3.11 C. R. Bard
14.3.12 Marine Polymer Technologies
14.3.13 Cordis
